MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Sleep disorders. See also Restless legs syndrome: Clinical features"

  • 2019 International Congress

    Baseline hyposmia and RBD symptoms are associated with faster, but differential, cognitive decline at 2 years in the PPMI study

    G. Nomikos, J. Xiao, M. Yang, V. Irzhevsky (Cambridge, MA, USA)

    Objective: To explore the potential role of baseline hyposmia and RBD symptoms on progression of cognitive decline at 2 years. Background: Cognitive decline in PD…
  • 2019 International Congress

    The effects of zonisamide on motor and non-motor symptoms in patients with Parkinson’s disease: a 3-month open-label study

    K. Suzuki, H. Fujita, T. Matsubara, T. Kadowaki, K. Funakoshi, Y. Watanabe, T. Shiina, H. Sakuramoto, M. Hamaguchi, K. Hirata (Tochigi, Japan)

    Objective: To investigate the effect of zonisamide (ZNS) on motor and non-motor symptoms, such as depressive symptoms and sleep problems, in patients with Parkinson’s disease…
  • 2019 International Congress

    Motor and non-motor symptoms related to sleep disturbances in Parkinson’s disease

    D. van Wamelen, V. Leta, A. Podlewska, Y. Wan, A. Sauerbier, A. Rizos, P. Martinez-Martin, K. Chaudhuri (Madrid, Spain)

    Objective: To assess which (non-)motor symptoms are associated with the longitudinal development of sleep disturbances, one of the major non-motor symptoms (NMS) in Parkinson’s disease…
  • 2019 International Congress

    Relationship between non-motor symptoms, medications and sleep interruptions in patients with Parkinson’s disease

    S. Anis, A. Thaler, M. Kestenbaum, A. Orr-Urtreger, M. Gana-Weisz, O. Goldstein, R. Hen Simon, J. Cederbaum, J. Hausdorff, N. Giladi, A. Mirelman (Tel Aviv, Israel)

    Objective: To explore the relationship between sleep quality and medical treatment in patients with PD. Background: Disturbances, autonomic dysfunction and depression are common non-motor symptoms…
  • 2019 International Congress

    Actigraphically Characterized Infradian Rest-Activity Rhythms in Parkinson’s Disease

    C. Brooks, R. Koehler, MK. Erb, F. Mortazavi, J. Bhangu, K. Thomas (Boston, MA, USA)

    Objective: To characterize infradian variations across the week in participants with Parkinson’s disease (PD), preliminary analyses were conducted as a means to develop a process…
  • 2019 International Congress

    Sleep Aspects on Video-Polysomnography in P.A53T SNCA Mutation Carriers

    AM. Simitsi, C. Koros, M. Stamelou, D. Papadimitrioy, A. Bougea, I. Pachi, N. Papagiannakis, R. Antonelou, E. Angelopoulou, K. Lourentzos, L. Stefanis, A. Bonakis (Athens, Greece)

    Objective: To determine whether REM sleep behavior disorder (RBD) and other sleep abnormalities occur in carriers of the p.A53T alpha-synuclein gene (SNCA) mutation, the prototypical…
  • 2019 International Congress

    The prevalence and features of REM sleep behaviour disorder in Essential Tremor: a polysomnography study

    P. Bugalho, M. Salavisa, C. Borbinha, M. Fernandes, B. Meira, R. Barbosa, M. Mendonça (Lisboa, Portugal)

    Objective: To assess the prevalence and characteristics of video-polysomnography (PSG) confirmed REM sleep behaviour disorder (RBD) in patients with Essential Tremor (ET). Background: ET has…
  • 2019 International Congress

    Biomarkers of idiopathic REM sleep behavior disorder versus RBD within narcolepsy

    E. Antelmi, F. Pizza, Y. Sosero, V. Donadio, A. Incensi, R. Liguori, G. Plazzi (Bologna, Italy)

    Objective: We compared iRBD versus secondary RBD due to narcolepsy, searching for discriminating clinical, neurophysiological and pathological biomarkers. Background: Idiopathic REM sleep behavior disorder (iRBD)…
  • 2019 International Congress

    Applicability of questionnaires and study of the prevalence of REM Sleep Behavior Disorder (RBD) in Parkinson’s disease

    M. Cordellini, A. Machado, C. Costa (Curitiba, Brazil)

    Objective: Evaluation of patients with idiopathic Parkinson's disease regarding the presence of RBD, application of the questionnaires, and correlation between the diagnosis of RBD by…
  • 2019 International Congress

    The influence of gender, associated neurological disorder and motive for polysomnography (PSG) in the manifestations of REM sleep behaviour disorder (RBD)

    P. Bugalho, M. Salavisa (Lisbon, Portugal)

    Objective: To access the interrelation and relative influence of gender, associated neurological disorder and context of referral to PSG on the manifestations of  (RBD). Background:…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley